Skip to main content
. 2014 Dec 30;75(2):356–361. doi: 10.1136/annrheumdis-2014-205698

Figure 3.

Figure 3

Relative changes in antibody levels in relation to treatment response after 3 months of methotrexate therapy (A) and after 9 months of add-on therapy (B) in early rheumatoid arthritis. CCP, cyclic citrullinated peptide; CEP-1, citrullinated α-enolase peptide-1; cVim, citrullinated vimentin peptide; cFib, citrullinated fibrinogen peptide.